AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Does Tailored Education in Asthma Care Help Improve Patient Satisfaction, Adherence, and Quality of Life (TEACH) Trial
Phase 4
Completed
- Conditions
- Asthma
- Interventions
- Behavioral: Educational intervention
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2011-01-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 160
- Registration Number
- NCT00687310
Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
Completed
- Conditions
- Hypercholesterolemia
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 8000
- Registration Number
- NCT00687492
- Locations
- 🇻🇳
Research Site, Hcmc, Vietnam
Safety, Tolerability and Pharmacokinetics of Inhaled Doses of AZD4818 in Healthy Japanese Male Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: PlaceboDrug: AZD4818
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2010-12-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 30
- Registration Number
- NCT00687232
- Locations
- 🇯🇵
Research Site, Osaka-city, Osaka, Japan
Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects
Phase 1
Completed
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: AZD0328Drug: Placebo
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 112
- Registration Number
- NCT00687141
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)
- First Posted Date
- 2008-05-30
- Last Posted Date
- 2008-06-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 40
- Registration Number
- NCT00687245
Positron Emission Tomography (PET) Study With [11C]AZ12713580 to Determine Central mGluR5 Receptor Occupancy of AZD2066
Phase 1
Completed
- Conditions
- Healthy
- First Posted Date
- 2008-05-29
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 6
- Registration Number
- NCT00686504
- Locations
- 🇸🇪
Research Site, Stockholm, Sweden
Positron Emission Tomography Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male Subjects
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: AZD3480Radiation: 2-[18F]-F-A85380
- First Posted Date
- 2008-05-29
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 9
- Registration Number
- NCT00686413
- Locations
- 🇸🇪
Research Site, Stockholm, Sweden
AZD6140 Oral Contraceptive Interaction Study
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2008-05-29
- Last Posted Date
- 2010-12-02
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT00685906
- Locations
- 🇺🇸
Research Site, Miami, Florida, United States
Investigate the Effect on the QT/QTc Interval of Repeated and Escalating Doses of AZD3480 During 6 Days
- First Posted Date
- 2008-05-29
- Last Posted Date
- 2008-09-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 75
- Registration Number
- NCT00686179
Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy Subjects
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2010-12-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 110
- Registration Number
- NCT00684502
- Locations
- 🇸🇪
Research Site, Stockholm, Sweden
© Copyright 2025. All Rights Reserved by MedPath